Union Therapeutics is Biotechnology in Denmark that focus on infectious diseases business. Founded in 2011. They cover business area such as developer, novel drug, inflammatory, infectious disease, broad applicability, therapeutic area, compound, both microbiological and immunological effect, a novel mode, action, bacteria, attractive anti-resistance property, patient, protection, harm.
2011
( 13 years old in 2024 )
Infectious Diseases
-
Tuborg Havnevej 18
2900 Hellerup
Denmark
Private
developernovel druginflammatoryinfectious diseasebroad applicabilitytherapeutic areacompoundboth microbiological and immunological effecta novel modeactionbacteriaattractive anti-resistance propertypatientprotectionharm
* We use standard office opening hours in near Union Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Union Therapeutics is Biotechnology business from Denmark that founded in 2011 (13 years old in 2024), Union Therapeutics business is focusing on Infectious Diseases.
Union Therapeutics headquarter office and corporate office address is located in Tuborg Havnevej 18 2900 Hellerup Denmark.
Union Therapeutics was founded in Denmark.
In 2024, Union Therapeutics is currently focus on infectious diseases sector.
Above is snippet of Google Trends for "infectious diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Union Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
